Search
for
Sort by
Research 31–60 of 161
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- Novel drugs of United States Food and Drug Administration approved in 2024
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Exploring novel management options for alopecia areata
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Treatment of alopecia areata with JAK inhibitors
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Alopecia Areata Treatment: Past, Present, and Future
- Novel investigational drugs for alopecia areata and future perspectives
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- Advances in the mechanism and new therapies of alopecia areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Hair
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis